Kolon Life Science

1 in Phase 3

Quick facts

Phase 3 pipeline

Invossa K Inj. · Orthopedics / Rheumatology
Invossa K is a gene therapy that delivers TGF-β1 to stimulate cartilage regeneration and reduce joint degeneration in osteoarthritis.

Phase 2 pipeline

KLS-2031

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: